Recombinant VEGF (Bevacizumab Biosimilar) 抗体
适用: 人
FACS, ELISA, WB, BR, IP
宿主: 兔
Chimeric
unconjugated
Recombinant Antibody
-
- 抗原 See all VEGF (Bevacizumab Biosimilar) products
- VEGF (Bevacizumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
- 兔
-
克隆类型
- Chimeric
-
标记
- This VEGF (Bevacizumab Biosimilar) antibody is un-conjugated
-
应用范围
- Flow Cytometry (FACS), ELISA, Western Blotting (WB), Blocking Reagent (BR), Immunoprecipitation (IP)
- 特异性
- This antibody binds native and reduced human VEGF (isoform 165).
- 产品特性
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- 纯化方法
- Purified antibody.
- 纯度
- > 98 % as determined by SDS-PAGE
- 内毒素水平
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- 免疫原
- Recombinant human VEGF.
- 亚型
- IgG kappa
-
anti-VEGF (Bevacizumab Biosimilar) antibody
Research Grade 适用: 人 ELISA 宿主: Humanized Monoclonal unconjugated Recombinant Antibody
-
- 应用备注
- This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.
- 说明
-
NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- 限制
- 仅限研究用
-
- 缓冲液
- PBS with 0.02 % Proclin 300.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- 抗原
- VEGF (Bevacizumab Biosimilar)
- Abstract
- VEGF (Bevacizumab Biosimilar) 产品
- 别名
- MVCD1 antibody, VEGF antibody, VPF antibody, vascular endothelial growth factor A antibody, VEGFA antibody
- 背景
- Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF
- UniProt
- P15692
-
You are here:
